BioSpace News Archive

Press Releases

Jasper Therapeutics to Present Preclinical Briquilimab Data at the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting

October 25, 2024
·
6 min read
Press Releases

Dupixent® (dupilumab) Late-Breaking Positive Phase 3 Data in Chronic Spontaneous Urticaria to Be Presented at ACAAI

October 25, 2024
·
22 min read
Press Releases

EDAP to Announce Third Quarter 2024 Financial Results on November 7, 2024

October 25, 2024
·
1 min read
Press Releases

Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson’s Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress

October 25, 2024
·
11 min read
Press Releases

X4 Pharmaceuticals to Report Third-Quarter 2024 Financial and Phase 2 Chronic Neutropenia Study Results During Conference Call and Webcast on November 13, 2024

October 25, 2024
·
1 min read
Press Releases

Press Release: Dupixent late-breaking positive phase 3 data in chronic spontaneous urticaria to be presented at ACAAI

October 25, 2024
·
15 min read
Press Releases

Bryn Pharma Appoints Joshua Ziel as Chief Executive Officer

October 25, 2024
·
3 min read
Press Releases

Bayer and Dewpoint Therapeutics sign Licensing Agreement for Heart Disease Program

October 25, 2024
·
5 min read
Press Releases

Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024

October 25, 2024
·
1 min read
Press Releases

Erasca Announces Strong Momentum for Naporafenib and RAS Targeting Franchise

October 25, 2024
·
10 min read